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Abstract The Leu3 protein of yeast is a dual-function 
regulator, stimulating transcription when the inducer ¢z-isopro- 
pyimalate (tx-IPM) is present and suppressing transcription when 
1he inducer is absent. Here we show that Leu3p retains both its 
positive and negative regulatory properties when expressed in 
mammalian cells or when added to a mammalian uclear extract. 
~-IPM stimulates reporter gene expression 15-20-fold, both in 
ivo and in vitro. The concentration of o~-IPM required for half- 
maximal stimulation in vitro is 2.5 × 104 M. No yeast-specific 
tactors other than Leu3p itself are required for up- or down- 
regulation. Since ct-IPM is not metabolized in mammalian cells, 
the Leu3p-ct-lPM system might be useful in gene therapy and 
other studies as a highly specific, externally controlled on/off 
switch of gene expression. 
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"ransactivator Leu3p; Gene therapy; Cross-species 
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~. Introduction 
Leu3p belongs to a family of lower eukaryotic transcrip- 
tional activators that have several features in common. Their 
!)NA binding domains conform to a Zn(II)2-Cys6 cluster lo- 
, ated near the N-terminus [1,2], they have acidic-hydrophobic 
ranscriptional ctivation domains, usually located near the C- 
~erminus [3-5], and some of them are modulated, i.e. changed 
~rom an inactive to an active form by a small effector mole- 
ule. For example, Gal4p responds to an unidentified inter- 
3nediate of galactose metabolism that alters the interaction 
~,etween Gal4p and the negative regulator GAL80 [4]; 
!'ut3p, an activator in the proline utilization pathway of yeast, 
esponds to proline [6]; Haplp responds to heme which ap- 
,arently affects both the binding of Haplp to DNA and the 
mmasking of its activation domain [7]; and Leu3p responds 
o ct-IPM, an early intermediate in leucine biosynthesis [8]. 
~eu3p binds to UASLEu motifs in the promoters of genes 
avolved in branched-chain amino acid biosynthesis and nitro- 
~en assimilation [9-11]. It does so irrespective of the presence 
,r absence of c~-IPM [10,12]. When ct-IPM is absent, Leu3p 
,.cts as a repressor [8,10,13]. When t~-IPM is present, the ac- 
ivation domain of Leu3p becomes available for interaction 
vith factor(s] of the transcription i itiation machinery and 
,.licits a strong activating signal [8]. 
The activation domains of Gal4p and Leu3p have been 
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shown to stimulate transcription not only in yeast, but also 
in mammalian cells, consistent with the idea that the appara- 
tus involved in gene activation has been conserved among 
eukaryotes [14,15]. By contrast, modulation of yeast (or other 
lower eukaryotic) transactivators apparently has not been 
demonstrated outside of their native environment. In some 
instances, such as in the case of Gal4p, modulation across 
species would be difficult to achieve since additional protein 
factors are required for masking and unmasking of the activa- 
tion domain, and possibly other functions [16,17]. Experi- 
ments with LAC9, a Gal4p-related transactivator from Kluy- 
veromyces lactis, support his notion: to achieve masking of 
LAC9 in mammalian cells, it was necessary to co-express 
GAL80 [18]. Moreover, masking could not be reversed by 
galactose, presumably because factors required for the un- 
masking process are absent from mammalian cells. 
We report here that Leu3p adopts a masked conformation 
in mammalian cells on its own and that unmasking can be 
achieved simply by including the inducer c~-IPM in the culture 
medium. Masked Leu3p causes repression, unmasked Leu3p 
causes activation of gene expression. 
2. Materials and methods 
2.1. Plasmid construction 
Plasmid pC3-LEU3 was constructed to express full-length Leu3p 
from the human cytomegalovirus (CMV) major intermediate early 
promoter in mammalian cells. A 3.1 kb fragment containing the 
LEU3 sequence from -45 to +3063 [19] was excised from plasmid 
pZRL [20] by complete digestion with EcoRl and partial digestion 
with HindlII. The fragment was separated on a 0.7% agarose gel 
and extracted with the QIAEX II gel extraction kit (QIAGEN Inc.). 
It was then ligated into the polylinker region of the expression vector 
pcDNA3 (Invitrogen) that had also been digested with EcoRI and 
HindlII. The plasmid carrying the luciferase (LUC) reporter gene 
was pGL3-LUC (Promega). To construct pGL3-UASL-LUC, four 
consecutive UASLEu 30-mers [10] were inserted at the SacI site of 
the polylinker region of pGL3-LUC. 
2.2. Transfection of mammalian cells and luciferase assays 
Mouse 30A5 preadipocytes [21], a cell line derived from 10Tl/2 
fibroblasts and kindly provided by K.-H. Kim, were cultured to about 
70% confluence, then transfected, incubated, and lysed according to 
published procedures [22]. Luciferase assays were performed by lumi- 
nometry following the supplier's protocol (Promega, Publication 
TM033). Transfection efficiency was monitored by cotransfecting the 
cells with pRSV-lacZ [22] and measuring I~-galactosidase ctivities. 
2.3. Preparation of nuclear extracts and in vitro transcription assays 
30A5 cells were harvested by centrifugation in a table-top centrifuge 
at 1000 ×g for 10 min. Nuclear extracts were prepared by established 
procedures [23]. In vitro transcription was carried out by the method 
of Sierra et al. [24]. Plasmid pML(C2AT)A-53sh, which carries the 
-53 to +10 nucleotide sequence of the adenovirus type 2 major late 
(Ad2-ML) promoter followed by a G-free cassette [25], was modified 
by inserting five consecutive UASLEu elements atthe unique SacI site 
of the Ad2-ML promoter. Modified or unmodified plasmid was 
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digested with PvulI, and the shorter of the two fragments obtained in 
each case served as template. The total volume of each transcription 
assay was 30 gl. Transcripts were electrophoresed on a 4% polyacry- 
lamide-urea gel, subjected to autoradiography, and quantitated by 
densitometry using an UltroScanXL laser densitometer. 
2.4. SDS-polyacrylamide g l electrophoresis and immunoblotting 
After cell lysis, performed according to established procedures (Pro- 
mega Publication TM033), aliquots of whole cell extract correspond- 
ing to 20 ~tg of total protein were subjected to SDS-polyacrylamide g l 
electrophoresis followed by immunoblotting. The antibodies used 
were prepared against a chimeric protein that contained the 28 C- 
terminal amino acid residues of Leu3p fused to key limpet hemocya- 
nin [26]. Immunoblotting was performed following existing protocols 
(Amersham International Life Science). 
2.5. Spec&l chemicals 
DL-et-Isopropylmalic a id was from Aldrich; ~-isopropylmalic a id 
was a gift from H.E. Umbarger. Highly purified yeast Leu3 protein 
was kindly provided by F. Zheng. 
3. Results 
3.1. Leu3p expressed in mammalian ceils can be modulated by 
cx-IPM 
To express full-length Leu3p in mammalian cells, we tran- 
siently transfected 30A5 mouse preadipocytes (a fibroblast- 
derived cell line) with a plasmid (pC3-LEU3) that carried 
the LEU3 gene behind a CMV promoter (see Section 2). A 
plasmid containing the luciferase gene controlled by an SV40 
promoter served as the reporter. The reporter plasmid was 
used either as such or with four UASLEu elements inserted 
upstream of the SV40 promoter, The luciferase activity ob- 
served with reporter plasmid devoid of UASLEu elements (Fig. 
1, column 1) was taken to reflect basal level expression. This 
level of expression did not change when either Leu3p alone or 
Leu3p and (x-IPM were present (columns 2,3), indicating that 
there was no 'squelching', i.e. sequestration of transcription 
factors by unbound Leu3p. Inserting UASLEu elements up- 
stream of the SV40 promoter esulted in a slight (<  2-fold) 
increase in luciferase activity (columns 4,5). This increase was 
probably caused by a weak interaction of factors present in 
30A5 cells with the UASLEu flanking regions (data not 
shown). The increase was ~-IPM-independent. In cells that 
had been cotransfected with UASLEu-containing reporter 
plasmid and pC3-LEU3, luciferase gene expression dropped 
about 4-fold relative to cells that carried only the reporter 
plasmid (compare columns 4,6). This negative ffect probably 
has two components: competition with the weakly interacting 
factors, and suppression of basal level transcription to about 
40% of normal (compare columns 1,6). Adding c~-IPM to cells 
that had been cotransfected with UASLEu-containing reporter 
plasmid and pC3-LEU3 led to strong activation of the repor- 
ter gene. At what appeared to be saturating levels of c~-IPM in 
the culture medium (10 mM), an overall increase in expression 
of about 17-fold was observed (compare columns 6,7). 
To determine if full-length Leu3p was expressed in the 
mouse cell line in both the presence and absence of c~-IPM, 
Western blots were performed using whole-cell lysates of 
30A5 cells (Fig. 2). The results show that Leu3p molecules 
of the expected mass (approx. 100 kDa [19]) were produced 
in transfected mammalian cells irrespective of the presence 
or absence of inducer (compare columns 2,3). No crossreact- 
ing material could be detected in non-transfected cells (col- 
umn 4). 
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Fig. 1. Regulation of reporter gene expression by yeast Leu3p and 
c~-IPM in mouse cells. Preadipocytes (30A5)were transfected as indi- 
cated and incubated for 48 h in the absence ( - )  or presence (+) of 
c~-IPM (10 mM). The cells were then lysed and assayed for transfec- 
tion efficiency and luciferase activity. Boxes labeled LEU3: cells 
were transfected with pC3-LEU3 where indicated (+). Boxes labeled 
UASL: cells were transfected either with pGL3-LUC (-)  or with 
pGL3-UASL-LUC (+). See Section 2 for further details. Columns: 
1, cells were transfected with pGL3-LUC reporter plasmid only (ba- 
sal level expression; o UASLEt: elements present); 2, cells were co- 
transfected with pGL3-LUC and the LEU3-containing plasmid pC3- 
LEU3; 3, same as column 2 except hat cells were incubated in the 
presence of ~x-IPM; 4, cells were transfected with pGL3-UASL-LUC 
only; 5, same as column 4 except that cells were incubated in the 
presence of a-IPM; 6, cells were cotransfected with pGL3-UASL- 
LUC and pC3-LEU3; 7, same as column 6 except that cells were 
incubated in the presence of cx-IPM. Increasing the ~x-IPM concen- 
tration from 10 to 20 mM did not change the -fold activation; de- 
creasing the c~-IPM concentration to 5 mM resulted in a smaller ac- 
tivation amplitude (not shown). No special effort was made to 
facilitate the uptake of a-IPM into the cells. The ~x-IPM concentra- 
tions given are those of the biologically active isomer. The error 
bars indicate S.D. of the mean calculated from three experimental 
samples assayed in duplicate. 
3.2. Negative and positive ffects of  Leu3p in a mammalian cell 
nuclear extract 
To substantiate further the idea that Leu3p is modulated in 
a mammalian environment in a fashion similar to what had 
been seen in yeast, we performed in vitro transcription assays 
using nuclear extract from untransfected 30A5 cells and 
Leu3p that had been purified to near homogeneity from yeast 
cells overproducing the protein [26]. Extract was incubated 
with a template that contained the Ad2-ML promoter fol- 
lowed by a G-free cassette (Fig. 3). To allow efficient binding 
of Leu3p, five copies of the UASLEu element were inserted 
upstream of the promoter. The amount of transcript produced 
in the absence of Leu3p and a- IPM is shown in Fig. 3A (lane 
1). Adding highly purified Leu3p but no a- IPM resulted in a 
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5-fold drop in the rate of transcription (lane 2). Adding both 
keu3p and ct-IPM caused strong activation of transcription 
(lanes 3-9), with a maximal amplitude between non-induced 
and induced levels of about 18-fold. Supplying the in vitro 
system with increasing concentrations of tx-IPM had a satura- 
tion effect (Fig. 3B). The cx-IPM concentration necessary to 
cruse half-maximal stimulation of transcription was 0.25 mM. 
q o again address the question of whether the negative ffect 
( f  Leu3p was due to squelching, Leu3p was added to an 
i~cubation mixture containing template without the UASLEu 
eiements. There was essentially no effect on transcription, 
v'hether ct-IPM was present or not (Fig. 3C, compare lanes 
1,2 with lanes 3,4). Fig, 3C further demonstrates that, like in 
l ie  in vivo experiment, the mere presence of the UASLEu 
e(ements caused a slight (2.5-fold), et-IPM- and Leu3p-inde- 
i endent activation (lanes 5,6). Again, this effect was abolished 
~,nd the basal level expression (as seen in lanes 1-4) was re- 
(uced (by 3-fold) when Leu3p was added (lane 7). Leu3p- 
(:ependent transcriptional ctivation (lane 9) specifically re- 
t uired c~-IPM since no activation was observed when [~-IPM 
,.,as used instead (lane 8). In fact, when [3-IPM replaced ot- 
I PM, Leu3p returned to its repressive mode. The amplitude 
),etween the repressed and activated levels in this experiment 
, :as 19-fold. 
. .  Discussion 
The results reported here are consistent with a scenario 
~ccording to which Leu3p synthesized in 30A5 cells enters 
~tae nucleus and binds to the UASLEu elements of the reporter 
~ene in a masked conformation that represses gene expression 
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:ig. 2. Immunoblot analysis of Leu3p synthesized in 30A5 cells. 
L,anes: 1, control, highly purified Leu3 protein from yeast; 2, 
whole-cell lysate of 30A5 cells transfected with pC3-LEU3 and incu- 
!~ated in the presence of cx-IPM (10 mM); 3, same as lane 2 except 
that cells were incubated in the absence of tx-IPM; 4, whole-cell ly- 
~ate of untransfected 30A5 cells. The position of three molecular 
weight markers is indicated (kDa). The arrowhead points to the po- 
sition of Leu3p (approx. 100 kDa). See Section 2 for further details. 
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Fig. 3. Regulation of gene expression by Leu3p and ct-IPM in vitro 
in a 30A5 cell nuclear extract. See Section 2 for preparation of nu- 
clear extracts and other details. (A) Autoradiograph of transcripts 
generated from a promoter containing UASLEu. Lanes: 1, control, 
neither Leu3p nor ct-IPM was present; 2-9, transcription i  the 
presence of a constant concentration f highly purified Leu3p (175 
ng per assay) and increasing concentrations of ct-IPM, as indicated. 
The concentrations given are those of the biologically active isomer. 
(B) Dependence of transcriptional ctivation (in arbitrary units) on 
ct-IPM concentration. The data points correspond to lanes 2-9 of 
A. (C) Comparison of templates lacking (lanes 1-4) or containing 
(lanes 5 9) UASLEu elements. Lanes: 1, incubation mixture con- 
tained neither Leu3p nor c~-IPM; 2, same as lane 1 except hat ct- 
IPM (1 mM) was present; 3, same as lane 1 except that purified 
Leu3p (175 ng) was present; 4, same as lane 1 except hat both ct- 
IPM and Leu3p were present; 5-7,9, same as lanes 1-4 except hat 
UASLEu elements were present in template; 8, same as lane 9 except 
that tx-IPM was replaced with ~-IPM (2 raM). 
below basal level. Externally supplied tz-IPM also enters the 
nucleus and causes a conformational change in Leu3p that 
allows the transcriptional ctivation domain to establish con- 
tact with the general transcription factors, thereby stimulating 
gene expression. A synopsis of these events is given in Fig. 4. 
Qualitatively and quantitatively, the behavior of Leu3p in 
mammalian cells and in mammalian cell nuclear extracts very 
much resembles that seen in its native yeast environment. For 
example, the presence of Leu3p causes a 2.5-5-fold drop in 
basal level expression of reporter genes in the mammalian 
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Fig. 4. Synopsis of LEU3- and a-IPM-dependent regulation of a 
reporter gene in mouse adipocytes. The top of the figure shows part 
of plasmid pC3-LEU3 that expresses the yeast LEU3 gene from a 
CMV promoter. A second plasmid, pGL3-UASL-LUC, carries the 
luciferase gene under the control of an SV40 promoter containing 
four copies of UASLEu elements. The expression of the LUC gene 
in the absence of LEU3 is identified as state I (corresponding to col- 
umn 4 of Fig. 1). In the presence of LEU3, but in the absence of 
a-IPM, LUC gene xpression is suppressed (state II, corresponding 
to column 6 of Fig. 1). When both LEU3 and a-IPM are present, 
LUC gene xpression is induced (state III, corresponding to column 
7 of Fig. 1). The open circle represents Leu3p in the absence of a- 
IPM (repressive mode), the shaded circle represents Leu3p in the 
presence of a-IPM (active mode). 
system, compared with a 4-5-fold negative ffect on specific 
gene expression in yeast [8,10,13]. The concentration of a- 
IPM needed for half-maximal activation by Leu3p is 0.25 
mM in mammalian uclear extract and 0.2 mM in yeast 
whole-cell extract [8]. The difference between repressed and 
fully activated levels of expression of target genes (15-20- 
fold) is also very similar in both organisms. It is evident 
from these observations that no yeast-specific factors other 
than Leu3p itself are required for reporter gene activation 
or repression. In this sense, Leu3p is a self-contained regula- 
tor. In particular, there appears to be no need for a specific 
activation domain masking factor (corresponding to, for ex- 
ample, GAL80 in the Gal4p induction system). It is highly 
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unlikely that such a masking factor would be elaborated in 
mammalian cells that do not normally contain a Leu3p-type 
regulator. Masking (and unmasking) of the transcriptional 
activation domain are therefore likely to be Leu3p intramolec- 
ular processes. 
The functioning of Leu3p in mammalian cells could be 
most easily explained if it were assumed that it interacted 
with analogous components of the yeast and mammalian 
transcription machineries, for both its positive and negative 
effects. However, the possibility that the detailed mechanism 
of action of Leu3p in mammalian cells is different from that in 
yeast (while still leading to similar results) cannot be excluded 
at this point. One reason for this caveat is the recent observa- 
tion that repression by Leu3p in yeast appears to depend on 
the negative factor Motlp, also known as yTAFII180 [27]; so 
far, a Motlp homolog has apparently not been identified in 
mammalian cells. 
The Leu3p-a-IPM system is highly specific. In yeast, the 
only proteins other than Leu3p itself that would be expected 
to interact with a-IPM are IPM isomerase (which intercon- 
verts a- and 13-IPM), a-IPM synthase (which produces a- 
IPM), and a hypothetical -IPM transporter in the inner mi- 
tochondrial membrane. All three are part of the leucine bio- 
synthetic pathway in yeast and are expected to be absent from 
mammalian cells which are incapable of synthesizing leucine. 
In agreement with this notion, we could not detect any cross- 
reacting material in 30A5 cells using polyclonal antibodies 
against 13-IPM dehydrogenase, the enzyme that catalyzes the 
third step in the leucine pathway (data not shown). The spe- 
cificity of the a-IPM-Leu3p interaction, i.e. the absence of 
pleiotropic effects of a-IPM, should be useful when triggering 
gene expression in developmental studies or in gene therapy 
experiments. Since the absence of the leucine pathway from 
mammalian cells eliminates the only known metabolic route 
for a-IPM, delivery of a-IPM should, and apparently does, 
result in a strong, persistent 'on' signal. Subsequent withhold- 
ing of a-IPM (the 'off' signal) should lead to a gradual return 
of gene silencing, governed by the rate of diffusion of a-IPM 
out of the cells. While the kinetics of these processes remain to 
be established, it is evident hat the Leu3p-a-IPM system has 
the potential to become a powerful alternative to regulatory 
systems depending on hormones [28] or antibiotics [29]. 
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